Jan 2017 $15 M No. 5 $10 to $50 million 1
HemoSonics, LLC: Raise no. 5, Jan 2017 × Investors in this round 1 investor had bought by the notice of Feb 14, 2017: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,058,685
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Virginia People named in the notice Francesco F. Viola · Executive Officer, Director · Manager Timothy Fischer · Executive Officer, Director · Manager Antoine P. Coulot · Director · Manager Josep P. Manent · Director · Manager Mark F. Wheeler · Director · Manager Philippe P. Barroux · Director · Manager William F. Walker · Director · Manager William P. Moffitt · Director · Manager Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ferghana Securities Inc. (CRD 43430) · broker-dealer E. Hunterson Henrie, II (CRD 2431896) · New York, New York Sold in no state named, and outside the US Remarks in the notice On fees: “Represents total commissions paid in combination of cash and warrants.”On the use of proceeds: “Proceeds are used for general working capital, which may include normal compensation to executive officers/managers.”Signed by Timothy J. Fischer, President and CEO. Source: SEC Form D, newest notice filed Feb 14, 2017. Read the notice at the SEC .
equity SEC Nov 2015 $4 M No. 4 $2 to $10 million 34
HemoSonics, LLC: Raise no. 4, Nov 2015 × Investors in this round 34 investors had bought by the notice of Aug 19, 2016: 34 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $8 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Virginia People named in the notice Timothy J. Fischer · Executive Officer, Director · Manager Francesco F. Viola · Director · Manager Josep P Manent · Director · Manager Mark F. Wheeler · Director William F. Walker · Director · Manager William P Moffitt · Director · Manager Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds are used for general working capital, which may include normal compensation to executed officers/managers.”Signed by Timothy J. Fischer, President and CEO. Source: SEC Form D, newest notice filed Aug 19, 2016. Read the notice at the SEC .
equity, options SEC Jul 2014 $4 M No. 3 $2 to $10 million 29
HemoSonics, LLC: Raise no. 3, Jul 2014 × Investors in this round 29 investors had bought by the notice of Aug 19, 2016: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $6 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Virginia People named in the notice Francesco F. Viola · Executive Officer, Director · Manager Timothy J. Fischer · Executive Officer, Director · Manager Josep P. Manent · Director · Manager Mark F. Wheeler · Director · Manager William F. Walker · Director · Manager William P. Moffitt · Director · Manager Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds are used for general working capital, which may include normal compensation to executive officers/managers.”Signed by Timothy J. Fischer, President and CEO. Source: SEC Form D, newest notice filed Aug 19, 2016. Read the notice at the SEC .
equity SEC Jan 2013 $1 M No. 2 Under $2 million 9
HemoSonics, LLC: Raise no. 2, Jan 2013 × Investors in this round 9 investors had bought by the notice of Jun 11, 2013: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Francesco Viola · Executive Officer, Director David Freed · Director Jonathan Sackier · Director Mark Wheeler · Director Matt Hantzmon · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by William F. Walker, Manager and President. Source: SEC Form D, newest notice filed Jun 11, 2013. Read the notice at the SEC .
equity SEC Nov 2008 $1 M No. 1 Under $2 million 7
HemoSonics, LLC: Raise no. 1, Nov 2008 × Investors in this round 7 investors had bought by the notice of Jun 28, 2010: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Francesco F Viola · Executive Officer Michael B Laurence · Executive Officer William F Walker · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by William F. Walker, Manager and President. Source: SEC Form D, newest notice filed Jun 28, 2010. Read the notice at the SEC .
equity, options SEC